Hyloris Follows On Transaction Scrutiny With Maxigesic IV Updates
The Company’s Partner Secured A Further Deal In Brazil
Following its recently announced leadership changes, Hyloris has made two announcements linked to the marketing of its combined pain therapy Maxigesic IV in Brazil and the US.
